Jad Chahoud

Chief Scientific & Innovation Officer- Orlando Health Cancer Institute. Driving Phase 1–3 trials, biotech partnerships & AI-enabled research 🧬💻

[Jad Chahoud @JadChahoud]

Excited to share that I’ve joined @OrlandoHealth Cancer Institute as Chief Scientific & Innovation Officer.

Grateful for the incredibly warm welcome from the OHCI team!
Onward and upward

#PatientsFirst #OrlandoHealth #Oncology #ClinicalTrials #Innovation #Biotech #Pharma

[Pavlos Msaouel @PavlosMsaouel]

1/5 Our latest #MsaouelLab article in @EurUrolOncol introduces RMC-COMPASS, the first prognostic model designed specifically for patients with SMARCB1-deficient #RenalMedullaryCarcinoma: https://t.co/ldHj2uqR2x #endRMC #MsaouelLab #rarecancers #kidneycancer

[Sumanta K. Pal, MD, FASCO @montypal]

Voting for the ASCO Election is now open. I am honored to be running as one of the candidates for the ASCO Board. Visit https://t.co/PU1xz0Tk5I to learn more about the candidates and place your vote!

[Jad Chahoud @JadChahoud]

💯 @shilpaonc! Beyond his visionary leadership. @montypal is a leader that passes the mirror test! Building the next generation of oncologists takes action. I watched Monty ask that junior faculty who drove trial enrollment take his NEJM authorship spot. He walks the talk @ASCO

[Shilpa Gupta, MD, FASCO @shilpaonc]

Couldn't agree more! @montypal led our @ASCO LDP program 2024-25 and we were fortunate to learn from his incredible insights on hands on leadership!
His visionary leadership is exactly what ASCO needs to expand the global footprint and nurture the next generation of leaders in oncology!

@IbiayiMD @minasedrakmd @NVijayvergiaMD @fumikochino @StephenChunMD @JadChahoud

[Jad Chahoud @JadChahoud]

@neerajaiims Congrats 🍾👑

[Pavlos Msaouel @PavlosMsaouel]

1/5 New in @EurUrolOncol: the largest series yet of metastasis-directed radiation therapy in SMARCB1-deficient #RenalMedullaryCarcinoma. Key finding that this cancer appears far more radiosensitive than clear cell kidney cancer: https://t.co/6z2uLjtBoc #endRMC #MsaouelLab

[Jad Chahoud @JadChahoud]

@PavlosMsaouel Great practice informing work as always! Thank you for leading the way in this rare cancer my friend 👑 onwards!

[Andy Hahn @OncHahn]

(1/4) Here's our clinical lab’s latest work led by @MitchellBoshkos, PGY-3, evaluating how cardiometabolic factors influence response to pre-operative ADT +/- ARPI in localized HRPCa in @pcan_journal
https://t.co/5cQ3v2GMBW

[Ryan Nipp, MD, MPH, MBA, FASCO @RyanNipp]

Accrual speed and characteristics of phase III U.S. cancer clinical trials with frequently used biomarkers in eligibility criteria.

https://t.co/UnzBwkTD22

@ASCO @CharlesJiangMD
#ASCOQLTY26 #Cancer #ClinicalTrials

[Jad Chahoud @JadChahoud]

@KidneyCancer @montypal Congrats super Monty!!! The best of the best 👑

[Andy Hahn @OncHahn]

Our thoughts on the recent approval of adjuvant pembro + belzutifan for ccRCC led by outstanding fellow @SM_Esagian in @ASCOPost https://t.co/sbvzMP9s4U @PavlosMsaouel

[Global Society of Rare Genitourinary Tumors @GTumors]

To mark Penile Cancer Awareness Day, the GSRGT is proud to officially launch PCARE — our new patient advocacy initiative supporting people affected by #PenileCancer.

If you are a patient or caregiver looking for support or guidance, please contact us at [email protected] 📩

Special thanks to @SpiessPhilippe, @LuisMedinaMD, and @JadChahoud for bringing this initiative to life.

@drgaganprakash @npaesa @CMercinelli @CurtisPettaway1 @AmerUrological @UroOnc @SUO_YUO @CAU_URO @AndreaNecchi @herneygarcia @PGrivasMDPhD @UroDocAsh @spsutkaMD @montypal @shilpaonc @orchidcancer @karima_oualla @VedangMurthy @UrogerliMD

[Pavlos Msaouel @PavlosMsaouel]

1/5 New in @UrolOncol: consensus statements from the IKCS North America 2025 Think Tank on trials for rare kidney cancers. 46 experts. 20 statements. One message: move beyond pooled “non-clear cell” #kidneycancer primary analyses: https://t.co/9GUSt2xrIK

[Laura Bukavina @LauraBukavinaMD]

Thank you for everything you do for GU research, for the countless hours you dedicate to reviewing for @EUplatinum and for continuing to push our field forward

[Pavlos Msaouel @PavlosMsaouel]

1/5 Our study on panitumumab-based EGFR blockade in renal medullary carcinoma (RMC) is out in Clinical Cancer Research: https://t.co/mU9znGC4mq #MsaouelLab, #endRMC #kidneycancer

[Ryan Nipp, MD, MPH, MBA, FASCO @RyanNipp]

Federal and Industry Sponsorship in US #Cancer Clinical Trials.

https://t.co/DGop58rH3O

@JAMA_current @JAMANetwork @JAMAOnc
#CancerResearch #ClinicalTrials
@DrJoeUnger @DrDawnHershman

[OncoDaily @oncodaily]

Outstanding Grand Rounds on AML Treatment Strategies with Yale University Expertise - Jad Chahoud

@JadChahoud

https://t.co/ZdRH5Qzj7a

[Jad Chahoud @JadChahoud]

@BraunMDPhD @ReneeSaliby @YaleCancer @YaleMed @SmilowCancer Congrats Super David!

[Jad Chahoud @JadChahoud]

@ZakhariaYousef @kidneycan @MayoCancerCare Congrats Youssef! Onwards 👑🍾

[Jad Chahoud @JadChahoud]

@dralainmina @YaleCancer @orlandohealth 👑

[Jad Chahoud @JadChahoud]

Grateful to have hosted Dr @dralainmina @YaleCancer at @orlandohealth Cancer Institute for an outstanding Grand Rounds on redefining cure in AML across the transplant continuum.

Thank you, Alain, for sharing your expertise and spending time with our OHCI team!#Leukemia